A Study Exploring the Use of Challenge Agents in Healthy Volunteers - Intervention Specific Appendix

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 10, 2021

Primary Completion Date

May 7, 2021

Study Completion Date

May 7, 2021

Conditions
Healthy
Interventions
DRUG

Indomethacin

Indomethacin capsules will be administered orally.

DIAGNOSTIC_TEST

Lactulose-mannitol

Lactulose-mannitol solution will be administered orally.

Trial Locations (1)

2170

Clinical Pharmacology Unit, Merksem

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT04821323 - A Study Exploring the Use of Challenge Agents in Healthy Volunteers - Intervention Specific Appendix | Biotech Hunter | Biotech Hunter